510(k) K181807

Solitaire 2 Revascularization Device, Solitaire Platinum Revascularization Device (Solitaire Revascularization Device) by Micro Therapeutics, Inc. D/B/A Ev3 Neurovascular — Product Code POL

K181807 is an FDA 510(k) premarket notification submitted by Micro Therapeutics, Inc. D/B/A Ev3 Neurovascular for the device "Solitaire 2 Revascularization Device, Solitaire Platinum Revascularization Device (Solitaire Revascularization Device)". The FDA issued a decision of Substantially Equivalent on Mar 6, 2019. The device falls under product code POL (Neurovascular Mechanical Thrombectomy Device For Acute Ischemic Stroke Treatment), a Class II device regulated under 21 CFR 882.5600. Micro Therapeutics, Inc. D/B/A Ev3 Neurovascular has 31 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Mar 6, 2019
Date Received
Jul 6, 2018
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Neurovascular Mechanical Thrombectomy Device For Acute Ischemic Stroke Treatment
Device Class
Class II
Regulation Number
882.5600
Review Panel
NE
Submission Type
510(k)

A neurovascular mechanical thrombectomy device for acute ischemic stroke treatment is a prescription device used in the treatment of acute ischemic stroke to improve clinical outcomes. The device is delivered into the neurovasculature with an endovascular approach, mechanically removes thrombus from the body, and restores blood flow in the neurovasculature.

Need the full FDA record for Micro Therapeutics, Inc. D/B/A Ev3 Neurovascular? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K181807. Report a data issue: hello@regdatalab.com.